Key result
Pattern-recognition CTG classification severely limits fetal ECG monitoring from reducing intrapartum interventions.
Why the study?
STAN technology was introduced to reduce false positives and unnecessary intrapartum interventions associated with CTG, but recent evidence questions its clinical benefit.
Answers are grounded in this paper and cite their sources.
Cardiotocograph (CTG) was introduced into clinical practice to timely recognise features of the onset of decompensation so that timely action could be taken to avoid hypoxic- ischaemic encepha lopathy (HIE) or perinatal deaths. Unfortunately, systematic reviews have shown that classification of CTG traces into “normal, suspicious and pathological” (or “Category I, II and III in the USA) has not only failed to reduce intrapartum operative interventions, cerebral palsy and perinatal deaths, but it was also associated with significant inter- and interobserver variability. Fetal electrocardiograph (ECG) or ST-analysis (STAN) was introduced into clinical practice to reduce the false positive rate of cardiotocograph (CTG) and to reduce the rate of unnecessary intrapartum operative interventions such as emergency caesarean sections, vacuum and forceps births. Although the STAN technology is based on sound physiological principles, its Achilles’ Heel is the continued use of the CTG classifica tion tool using “normal, intermediary and abnormal” by arbitrarily grouping several features into different categories without any robust scientific evidence. This exposes the STAN technology to the same flaws of “pattern-recognition” and inter-and intra-observer variability. In the light of recent systematic reviews and meta-analysis showing no benefit in reducing emergency caesarean section and the most recent randomised controlled trial from Australia suggesting that introduction of STAN technology as an adjunct to CTG has failed to show any reduction in intrapartum operative interven tions, frontline clinicians have to ask the question: Is it time for the Requiem for STAN?
No takes yet. Share an insight, caveat, or question.
Edwin Chandraharan (2023) conducted an editorial in Fetal monitoring during labor. Fetal Electrocardiograph (ST-Analyser or STAN) vs. Cardiotocograph (CTG) alone or with Fetal Blood Sampling (FBS) was evaluated. The potential of fetal electrocardiograph (STAN) monitoring to reduce intrapartum interventions is severely limited by the continued use of unscientific pattern-recognition CTG classification tools.
Synapse has enriched 10 related papers. Consider them for comparative context: